2.1 The Effect of Pei's Soft Liver and Anti-bloating Pills on Improving Tumor Regression Rate in PLC Patients

2.1 The Effect of Pei's Soft Liver and Anti-bloating Pills on Improving Tumor Regression Rate in PLC Patients

Pei's Soft Liver and Anti-bloating Pills have the effect of strengthening the body and consolidating the foundation. "Strengthening the body" means supporting righteous qi, which in traditional Chinese medicine is equivalent to the body's own immune function in Western medicine. "Consolidating the foundation" means nurturing the body's inherent ability to resist disease. By strengthening the body and consolidating the foundation, physiological functions are restored, achieving the goal of restoring righteousness and repelling evil to treat illness. The purpose of "strengthening the body and consolidating the foundation" is to enhance and mobilize the body's intrinsic vitality, which shares certain similarities with modern molecular biology and immunology. When the patient's own immune function improves, it inhibits tumor growth. Pei's Soft Liver and Anti-bloating Pills directly act on the tumor itself by breaking down accumulation, eliminating tumors, activating blood circulation and removing blood stasis, softening hard masses and dispersing nodules—equivalent to the Western medical effect of eliminating tumors—and are superior to Western medicine in terms of minimizing bodily harm.

According to the World Health Organization's criteria for evaluating the efficacy of solid tumors, the two groups of cases were assessed for solid tumor response. Neither the treatment nor the control group achieved complete remission (CR); the treatment group had 12 cases of partial remission (PR), accounting for 35.29%, while the control group had 5 cases, accounting for 14.71%, indicating that the treatment group had a significantly higher PR rate than the control group; the treatment group had 17 cases of stable disease (SD), accounting for 50.00% of their cases, while the control group had 15 cases, accounting for 44.11%, showing that the treatment group had more stable disease cases than the control group; the treatment group had 5 cases of disease progression, accounting for 14.71% of their cases, while the control group had 14 cases, accounting for 41.18%, indicating that the treatment group had a significantly lower disease progression rate than the control group. According to the rank-sum test, the difference in tumor response between the two groups was statistically significant (P<0.05), with the treatment group performing better than the control group. The difference in the effective rate of tumor response between the two groups (CR+PR) was also statistically significant; the stable disease rate (CR+PR+SD) was 29 cases (85.29%) for the treatment group and 20 cases (58.82%) for the control group. The stable disease rate was analyzed by χ² test, with P<0.05, indicating statistical significance, and the treatment group had a higher stable disease rate than the control group. This shows that Pei's Soft Liver and Anti-bloating Pills have a certain anti-tumor effect, with better efficacy than the Western medicine-only treatment group.